Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

SYNTAX Score and Outcomes of Coronary Revascularization in Diabetic Patients.

Kundu A, Sardar P, O'Day K, Chatterjee S, Owan T, Dawn Abbott J.

Curr Cardiol Rep. 2018 Mar 23;20(5):28. doi: 10.1007/s11886-018-0971-1. Review.

PMID:
29572680
2.

Global risk classification and clinical SYNTAX (synergy between percutaneous coronary intervention with TAXUS and cardiac surgery) score in patients undergoing percutaneous or surgical left main revascularization.

Capodanno D, Caggegi A, Miano M, Cincotta G, Dipasqua F, Giacchi G, Capranzano P, Ussia G, Di Salvo ME, La Manna A, Tamburino C.

JACC Cardiovasc Interv. 2011 Mar;4(3):287-97. doi: 10.1016/j.jcin.2010.10.013.

3.

Coronary artery bypass graft surgery vs percutaneous interventions in coronary revascularization: a systematic review.

Deb S, Wijeysundera HC, Ko DT, Tsubota H, Hill S, Fremes SE.

JAMA. 2013 Nov 20;310(19):2086-95. doi: 10.1001/jama.2013.281718. Review.

PMID:
24240936
4.

Widening clinical applications of the SYNTAX Score.

Farooq V, Head SJ, Kappetein AP, Serruys PW.

Heart. 2014 Feb;100(4):276-87. doi: 10.1136/heartjnl-2013-304273. Epub 2013 Jul 22. Review.

PMID:
23878176
5.

Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II.

Farooq V, van Klaveren D, Steyerberg EW, Meliga E, Vergouwe Y, Chieffo A, Kappetein AP, Colombo A, Holmes DR Jr, Mack M, Feldman T, Morice MC, Ståhle E, Onuma Y, Morel MA, Garcia-Garcia HM, van Es GA, Dawkins KD, Mohr FW, Serruys PW.

Lancet. 2013 Feb 23;381(9867):639-50. doi: 10.1016/S0140-6736(13)60108-7.

PMID:
23439103
6.

Predictive accuracy of SYNTAX score for predicting long-term outcomes of unprotected left main coronary artery revascularization.

Chakravarty T, Buch MH, Naik H, White AJ, Doctor N, Schapira J, Mirocha JM, Fontana G, Forrester JS, Makkar R.

Am J Cardiol. 2011 Feb 1;107(3):360-6. doi: 10.1016/j.amjcard.2010.09.029.

PMID:
21256999
7.

Coronary artery bypass grafting vs. percutaneous coronary intervention for patients with three-vessel disease: final five-year follow-up of the SYNTAX trial.

Head SJ, Davierwala PM, Serruys PW, Redwood SR, Colombo A, Mack MJ, Morice MC, Holmes DR Jr, Feldman TE, Ståhle E, Underwood P, Dawkins KD, Kappetein AP, Mohr FW.

Eur Heart J. 2014 Oct 21;35(40):2821-30. doi: 10.1093/eurheartj/ehu213. Epub 2014 May 21.

PMID:
24849105
8.

One-stop hybrid coronary revascularization versus coronary artery bypass grafting and percutaneous coronary intervention for the treatment of multivessel coronary artery disease: 3-year follow-up results from a single institution.

Shen L, Hu S, Wang H, Xiong H, Zheng Z, Li L, Xu B, Yan H, Gao R.

J Am Coll Cardiol. 2013 Jun 25;61(25):2525-33. doi: 10.1016/j.jacc.2013.04.007. Epub 2013 Apr 23.

9.

SYNTAX Score and Long-Term Outcomes: The BARI-2D Trial.

Ikeno F, Brooks MM, Nakagawa K, Kim MK, Kaneda H, Mitsutake Y, Vlachos HA, Schwartz L, Frye RL, Kelsey SF, Waseda K, Hlatky MA; BARI-2D Study Group.

J Am Coll Cardiol. 2017 Jan 31;69(4):395-403. doi: 10.1016/j.jacc.2016.10.067.

10.

Long-term forecasting and comparison of mortality in the Evaluation of the Xience Everolimus Eluting Stent vs. Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization (EXCEL) trial: prospective validation of the SYNTAX Score II.

Campos CM, van Klaveren D, Farooq V, Simonton CA, Kappetein AP, Sabik JF 3rd, Steyerberg EW, Stone GW, Serruys PW; EXCEL Trial Investigators.

Eur Heart J. 2015 May 21;36(20):1231-41. doi: 10.1093/eurheartj/ehu518. Epub 2015 Jan 12.

PMID:
25583761
11.

Worse clinical outcomes following percutaneous coronary intervention with a high SYNTAX score: A systematic review and meta-analysis.

Bundhun PK, Bhurtu A, Huang F.

Medicine (Baltimore). 2017 Jun;96(24):e7140. doi: 10.1097/MD.0000000000007140. Review.

12.

Risk stratification in 3-vessel coronary artery disease: Applying the SYNTAX Score II in the Heart Team Discussion of the SYNTAX II trial.

Campos CM, Stanetic BM, Farooq V, Walsh S, Ishibashi Y, Onuma Y, Garcia-Garcia HM, Escaned J, Banning A, Serruys PW; SYNTAX II Study Group.

Catheter Cardiovasc Interv. 2015 Nov 15;86(6):E229-38. doi: 10.1002/ccd.25907. Epub 2015 May 6.

PMID:
25946686
13.

Usefulness of SYNTAX score to select patients with left main coronary artery disease to be treated with coronary artery bypass graft.

Capodanno D, Capranzano P, Di Salvo ME, Caggegi A, Tomasello D, Cincotta G, Miano M, Patané M, Tamburino C, Tolaro S, Patané L, Calafiore AM, Tamburino C.

JACC Cardiovasc Interv. 2009 Aug;2(8):731-8. doi: 10.1016/j.jcin.2009.06.003.

14.

Quality of Life After Surgery or DES in Patients With 3-Vessel or Left Main Disease.

Abdallah MS, Wang K, Magnuson EA, Osnabrugge RL, Kappetein AP, Morice MC, Mohr FA, Serruys PW, Cohen DJ; SYNTAX Trial Investigators.

J Am Coll Cardiol. 2017 Apr 25;69(16):2039-2050. doi: 10.1016/j.jacc.2017.02.031.

15.

Bypass Grafting Versus Percutaneous Intervention-Which Is Better in Multivessel Coronary Disease: Lessons From SYNTAX and Beyond.

Farooq V, Serruys PW.

Prog Cardiovasc Dis. 2015 Nov-Dec;58(3):316-34. doi: 10.1016/j.pcad.2015.10.002. Epub 2015 Oct 31. Review.

PMID:
26529569
16.

Validation of SYNTAX (Synergy between PCI with Taxus and Cardiac Surgery) score for prediction of outcomes after unprotected left main coronary revascularization.

Kim YH, Park DW, Kim WJ, Lee JY, Yun SC, Kang SJ, Lee SW, Lee CW, Park SW, Park SJ.

JACC Cardiovasc Interv. 2010 Jun;3(6):612-23. doi: 10.1016/j.jcin.2010.04.004.

17.

Three-year outcomes after percutaneous coronary intervention and coronary artery bypass grafting in patients with heart failure: from the CREDO-Kyoto percutaneous coronary intervention/coronary artery bypass graft registry cohort-2†.

Marui A, Kimura T, Nishiwaki N, Komiya T, Hanyu M, Shiomi H, Tanaka S, Sakata R; CREDO-Kyoto PCI/CABG Registry Cohort-2 Investigators.

Eur J Cardiothorac Surg. 2015 Feb;47(2):316-21; discussion 321. doi: 10.1093/ejcts/ezu131. Epub 2014 Mar 23.

PMID:
24662243
18.

Five-year outcomes in patients with left main disease treated with either percutaneous coronary intervention or coronary artery bypass grafting in the synergy between percutaneous coronary intervention with taxus and cardiac surgery trial.

Morice MC, Serruys PW, Kappetein AP, Feldman TE, Ståhle E, Colombo A, Mack MJ, Holmes DR, Choi JW, Ruzyllo W, Religa G, Huang J, Roy K, Dawkins KD, Mohr F.

Circulation. 2014 Jun 10;129(23):2388-94. doi: 10.1161/CIRCULATIONAHA.113.006689. Epub 2014 Apr 3.

PMID:
24700706
19.

Genetics of coronary artery disease: should they impact the choice of revascularization?

Hui SK, Lindale E, Sun L, Ruel M.

Curr Opin Cardiol. 2018 Nov;33(6):605-612. doi: 10.1097/HCO.0000000000000560.

PMID:
30188420
20.

Long-term outcome of PCI versus CABG in insulin and non-insulin-treated diabetic patients: results from the FREEDOM trial.

Dangas GD, Farkouh ME, Sleeper LA, Yang M, Schoos MM, Macaya C, Abizaid A, Buller CE, Devlin G, Rodriguez AE, Lansky AJ, Siami FS, Domanski M, Fuster V; FREEDOM Investigators.

J Am Coll Cardiol. 2014 Sep 23;64(12):1189-97. doi: 10.1016/j.jacc.2014.06.1182.

Supplemental Content

Support Center